List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Diagnostic Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts 2017-2028
2.2 Global Diagnostic Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2028
2.3 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Diagnostic Radiopharmaceuticals Sales by Region
2.4.1 Global Diagnostic Radiopharmaceuticals Sales by Region (2017-2022)
2.4.2 Global Sales Diagnostic Radiopharmaceuticals by Region (2023-2028)
2.5 Global Diagnostic Radiopharmaceuticals Revenue by Region
2.5.1 Global Diagnostic Radiopharmaceuticals Revenue by Region (2017-2022)
2.5.2 Global Diagnostic Radiopharmaceuticals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global Top Diagnostic Radiopharmaceuticals Manufacturers by Sales (2017-2022)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diagnostic Radiopharmaceuticals in 2021
3.2 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2017-2022)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals Revenue in 2021
3.3 Global Diagnostic Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Diagnostic Radiopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diagnostic Radiopharmaceuticals Sales by Type
4.1.1 Global Diagnostic Radiopharmaceuticals Historical Sales by Type (2017-2022)
4.1.2 Global Diagnostic Radiopharmaceuticals Forecasted Sales by Type (2023-2028)
4.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
4.2 Global Diagnostic Radiopharmaceuticals Revenue by Type
4.2.1 Global Diagnostic Radiopharmaceuticals Historical Revenue by Type (2017-2022)
4.2.2 Global Diagnostic Radiopharmaceuticals Forecasted Revenue by Type (2023-2028)
4.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
4.3 Global Diagnostic Radiopharmaceuticals Price by Type
4.3.1 Global Diagnostic Radiopharmaceuticals Price by Type (2017-2022)
4.3.2 Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Diagnostic Radiopharmaceuticals Sales by Application
5.1.1 Global Diagnostic Radiopharmaceuticals Historical Sales by Application (2017-2022)
5.1.2 Global Diagnostic Radiopharmaceuticals Forecasted Sales by Application (2023-2028)
5.1.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
5.2 Global Diagnostic Radiopharmaceuticals Revenue by Application
5.2.1 Global Diagnostic Radiopharmaceuticals Historical Revenue by Application (2017-2022)
5.2.2 Global Diagnostic Radiopharmaceuticals Forecasted Revenue by Application (2023-2028)
5.2.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application
5.3.1 Global Diagnostic Radiopharmaceuticals Price by Application (2017-2022)
5.3.2 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diagnostic Radiopharmaceuticals Market Size by Type
6.1.1 North America Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
6.1.2 North America Diagnostic Radiopharmaceuticals Revenue by Type (2017-2028)
6.2 North America Diagnostic Radiopharmaceuticals Market Size by Application
6.2.1 North America Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
6.2.2 North America Diagnostic Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 North America Diagnostic Radiopharmaceuticals Market Size by Country
6.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country (2017-2028)
6.3.2 North America Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals Market Size by Type
7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Type (2017-2028)
7.2 Europe Diagnostic Radiopharmaceuticals Market Size by Application
7.2.1 Europe Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
7.2.2 Europe Diagnostic Radiopharmaceuticals Revenue by Application (2017-2028)
7.3 Europe Diagnostic Radiopharmaceuticals Market Size by Country
7.3.1 Europe Diagnostic Radiopharmaceuticals Sales by Country (2017-2028)
7.3.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Type
8.1.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
8.1.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Type (2017-2028)
8.2 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Application
8.2.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
8.2.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Application (2017-2028)
8.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region
8.3.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2017-2028)
8.3.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Diagnostic Radiopharmaceuticals Market Size by Type
9.1.1 Latin America Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
9.1.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Type (2017-2028)
9.2 Latin America Diagnostic Radiopharmaceuticals Market Size by Application
9.2.1 Latin America Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
9.2.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Application (2017-2028)
9.3 Latin America Diagnostic Radiopharmaceuticals Market Size by Country
9.3.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country (2017-2028)
9.3.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Type
10.1.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Type (2017-2028)
10.1.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Type (2017-2028)
10.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Application
10.2.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Application (2017-2028)
10.2.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Application (2017-2028)
10.3 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Country
10.3.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2017-2028)
10.3.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Corporation Information
11.1.2 Cardinal Health Overview
11.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cardinal Health Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Overview
11.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GE Healthcare Recent Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Corporation Information
11.3.2 Curium Pharma Overview
11.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Curium Pharma Recent Developments
11.4 Jubilant Pharma
11.4.1 Jubilant Pharma Corporation Information
11.4.2 Jubilant Pharma Overview
11.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jubilant Pharma Recent Developments
11.5 Bracco Imaging
11.5.1 Bracco Imaging Corporation Information
11.5.2 Bracco Imaging Overview
11.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bracco Imaging Recent Developments
11.6 Advanced Accelerator Applications
11.6.1 Advanced Accelerator Applications Corporation Information
11.6.2 Advanced Accelerator Applications Overview
11.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Advanced Accelerator Applications Recent Developments
11.7 SIEMENS
11.7.1 SIEMENS Corporation Information
11.7.2 SIEMENS Overview
11.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 SIEMENS Recent Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Corporation Information
11.8.2 China Isotope & Radiation Overview
11.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 China Isotope & Radiation Recent Developments
11.9 Dongcheng Pharmaceutical Group
11.9.1 Dongcheng Pharmaceutical Group Corporation Information
11.9.2 Dongcheng Pharmaceutical Group Overview
11.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dongcheng Pharmaceutical Group Recent Developments
11.10 Lantheus
11.10.1 Lantheus Corporation Information
11.10.2 Lantheus Overview
11.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lantheus Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Corporation Information
11.11.2 Eli Lilly Overview
11.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eli Lilly Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
12.2 Diagnostic Radiopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diagnostic Radiopharmaceuticals Production Mode & Process
12.4 Diagnostic Radiopharmaceuticals Sales and Marketing
12.4.1 Diagnostic Radiopharmaceuticals Sales Channels
12.4.2 Diagnostic Radiopharmaceuticals Distributors
12.5 Diagnostic Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Diagnostic Radiopharmaceuticals Industry Trends
13.2 Diagnostic Radiopharmaceuticals Market Drivers
13.3 Diagnostic Radiopharmaceuticals Market Challenges
13.4 Diagnostic Radiopharmaceuticals Market Restraints
14 Key Findings in The Global Diagnostic Radiopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
